Rain Oncology RAIN Stock
1.21 USD
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
44.01M USD
LOW - HIGH [24H]
0.0000
-
0.0000 USD
VOLUME [24H]
0 USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD
Rain Oncology Price Chart
Rain Oncology RAIN Financial and Trading Overview
| Rain Oncology stock price | 1.21 USD |
| Previous Close | 1.27 USD |
| Open | 1.23 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 800 |
| Day's Range | 1.23 - 1.35 USD |
| 52 Week Range | 0.94 - 14.48 USD |
| Volume | 1.1M USD |
| Avg. Volume | 1.43M USD |
| Market Cap | 47.27M USD |
| Beta (5Y Monthly) | 0.015407 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.81 USD |
RAIN Valuation Measures
| Enterprise Value | -63366764 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.04 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.5 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.779 |
Trading Information
Rain Oncology Stock Price History
| Beta (5Y Monthly) | 0.015407 |
| 52-Week Change | -43.96% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 14.48 USD |
| 52 Week Low | 0.94 USD |
| 50-Day Moving Average | 5.63 USD |
| 200-Day Moving Average | 7.02 USD |
RAIN Share Statistics
| Avg. Volume (3 month) | 1.43M USD |
| Avg. Daily Volume (10-Days) | 1.96M USD |
| Shares Outstanding | 26.52M |
| Float | 7.74M |
| Short Ratio | 0.57 |
| % Held by Insiders | 15.24% |
| % Held by Institutions | 86.90% |
| Shares Short | 1.64M |
| Short % of Float | 13.53% |
| Short % of Shares Outstanding | 4.50% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -42.068% |
| Return on Equity (ttm) | -75.41% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -81353000 USD |
| Net Income Avi to Common (ttm) | -78814000 USD |
| Diluted EPS (ttm) | -2.63 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 109.79M USD |
| Total Cash Per Share (mrq) | 3.02 USD |
| Total Debt (mrq) | 241K USD |
| Total Debt/Equity (mrq) | 0.26 USD |
| Current Ratio (mrq) | 5.8 |
| Book Value Per Share (mrq) | 2.6 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -67928000 USD |
| Levered Free Cash Flow (ttm) | -38758124 USD |
Profile of Rain Oncology
| Country | United States |
| State | CA |
| City | Newark |
| Address | 8000 Jarvis Avenue |
| ZIP | 94560 |
| Phone | 510 953 5559 |
| Website | https://www.rainoncology.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 63 |
Rain Oncology Inc., a late-stage precision oncology company, engages in developing therapies that target oncogenic drivers to genetically select patients in the United States. The company's lead product candidate is milademetan, a small molecule oral inhibitor of MDM2-p53 complex that reactivates p53. The company was formerly known as Rain Therapeutics Inc. and changed its name to Rain Oncology Inc. in December 2022. Rain Oncology Inc. was incorporated in 2017 and is headquartered in Newark, California.
Q&A For Rain Oncology Stock
What is a current RAIN stock price?
Rain Oncology RAIN stock price today per share is 1.21 USD.
How to purchase Rain Oncology stock?
You can buy RAIN shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Rain Oncology?
The stock symbol or ticker of Rain Oncology is RAIN.
Which industry does the Rain Oncology company belong to?
The Rain Oncology industry is Biotechnology.
How many shares does Rain Oncology have in circulation?
The max supply of Rain Oncology shares is 36.38M.
What is Rain Oncology Price to Earnings Ratio (PE Ratio)?
Rain Oncology PE Ratio is 0.00000000 now.
What was Rain Oncology earnings per share over the trailing 12 months (TTM)?
Rain Oncology EPS is 0 USD over the trailing 12 months.
Which sector does the Rain Oncology company belong to?
The Rain Oncology sector is Healthcare.
Rain Oncology RAIN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}